Friday, 19 June 2026
  
Login

Australia's most trusted
source of pharma news

Friday, 19 June 2026
News

Eyes on August PBS listing

Posted 19 June 2026 AM

Sandoz is actively working to avoid any market disruptions as Seqirus starts to discontinue its injectable antibiotic Benpen, with the company aiming to list its own product – and the most popular strength - on the PBS on 1 August.

Benzylpenicillin sodium, the active ingredient in BenPen, is widely used to treat infections caused by susceptible Gram-positive bacteria and to prevent infections following surgery and other medical procedures.

To see the whole article, please login


Latest Jobs
Pharma in Focus  Jobs

Marketing & Communications (2)

Sales & Customer Relations (26)

Access & Reimbursement (1)

Clinical & Medical, R&D (7)

Regulatory, Pharmacovigilance & QA (4)

Other (10)

MORE NEWS
Email this article to a friend
From:

 
 
  
Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.